134 related articles for article (PubMed ID: 12700347)
1. Inhibition of carnitine palmitoyltransferase in the rat small intestine reduces export of triacylglycerol into the lymph.
Washington L; Cook GA; Mansbach CM
J Lipid Res; 2003 Jul; 44(7):1395-403. PubMed ID: 12700347
[TBL] [Abstract][Full Text] [Related]
2. Interactions of inhibitors of carnitine palmitoyltransferase I and fibrates in cultured hepatocytes.
Gerondaes P; Alberti KG; Agius L
Biochem J; 1988 Jul; 253(1):169-73. PubMed ID: 3421940
[TBL] [Abstract][Full Text] [Related]
3. Effect of etomoxiryl-CoA on different carnitine acyltransferases.
Lilly K; Chung C; Kerner J; VanRenterghem R; Bieber LL
Biochem Pharmacol; 1992 Jan; 43(2):353-61. PubMed ID: 1739421
[TBL] [Abstract][Full Text] [Related]
4. Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme.
Weis BC; Cowan AT; Brown N; Foster DW; McGarry JD
J Biol Chem; 1994 Oct; 269(42):26443-8. PubMed ID: 7929365
[TBL] [Abstract][Full Text] [Related]
5. Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir.
Lopaschuk GD; McNeil GF; McVeigh JJ
Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):175-9. PubMed ID: 2779537
[TBL] [Abstract][Full Text] [Related]
6. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
[TBL] [Abstract][Full Text] [Related]
7. Expression and possible role of muscle-type carnitine palmitoyltransferase I during sperm development in the rat.
Adams SH; Esser V; Brown NF; Ing NH; Johnson L; Foster DW; McGarry JD
Biol Reprod; 1998 Dec; 59(6):1399-405. PubMed ID: 9828184
[TBL] [Abstract][Full Text] [Related]
8. The flux control coefficient of carnitine palmitoyltransferase I on palmitate beta-oxidation in rat hepatocyte cultures.
Spurway TD; Sherratt HA; Pogson CI; Agius L
Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):119-22. PubMed ID: 9173869
[TBL] [Abstract][Full Text] [Related]
9. Dietary medium-chain triglycerides can prevent changes in myosin and SR due to CPT-1 inhibition by etomoxir.
Rupp H; Schulze W; Vetter R
Am J Physiol; 1995 Sep; 269(3 Pt 2):R630-40. PubMed ID: 7573566
[TBL] [Abstract][Full Text] [Related]
10. Influence of carnitine acyltransferase inhibitors on the performance and metabolism of rat cardiac muscle.
Reinauer H; Adrian M; Rösen P; Schmitz FJ
J Clin Chem Clin Biochem; 1990 May; 28(5):335-9. PubMed ID: 2380671
[TBL] [Abstract][Full Text] [Related]
11. Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyl transferase inhibitor Etomoxir.
Schmitz FJ; Rösen P; Reinauer H
Horm Metab Res; 1995 Dec; 27(12):515-22. PubMed ID: 8750778
[TBL] [Abstract][Full Text] [Related]
12. Etomoxir, sodium 2-[6-(4-chlorophenoxy)hexyl] oxirane-2-carboxylate, inhibits triacylglycerol depletion in hepatocytes and lipolysis in adipocytes.
Spurway TD; Pogson CI; Sherratt HS; Agius L
FEBS Lett; 1997 Mar; 404(1):111-4. PubMed ID: 9074648
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated overexpression of liver carnitine palmitoyltransferase I in INS1E cells: effects on cell metabolism and insulin secretion.
Rubí B; Antinozzi PA; Herrero L; Ishihara H; Asins G; Serra D; Wollheim CB; Maechler P; Hegardt FG
Biochem J; 2002 May; 364(Pt 1):219-26. PubMed ID: 11988095
[TBL] [Abstract][Full Text] [Related]
14. Effects of carnitine palmitoyltransferase I inhibitors on hepatic hypertrophy.
Yotsumoto T; Naitoh T; Kitahara M; Tsuruzoe N
Eur J Pharmacol; 2000 Jun; 398(2):297-302. PubMed ID: 10854842
[TBL] [Abstract][Full Text] [Related]
15. ABCG5/G8 deficiency in mice reduces dietary triacylglycerol and cholesterol transport into the lymph.
Zhang LS; Xu M; Yang Q; Lou D; Howles PN; Tso P
Lipids; 2015 Apr; 50(4):371-9. PubMed ID: 25676339
[TBL] [Abstract][Full Text] [Related]
16. [Deposition of exogenous and endogenously generated unsaturated fatty acids in lipid droplets triacylglycerol as a mechanism of its sequestration in epithelial cells].
Fedorova EV; Fok EM; Bakhteeva VT; Lavrova EA; Parnova RG
Ross Fiziol Zh Im I M Sechenova; 2014 Aug; 100(8):964-78. PubMed ID: 25682688
[TBL] [Abstract][Full Text] [Related]
17. Myocardial contractility after infarction and carnitine palmitoyltransferase I inhibition in rats.
Günther J; Wagner K; Theres H; Schimke I; Born A; Scholz H; Vetter R
Eur J Pharmacol; 2000 Oct; 406(1):123-6. PubMed ID: 11011043
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by etomoxir of carnitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus.
Ratheiser K; Schneeweiss B; Waldhäusl W; Fasching P; Korn A; Nowotny P; Rohac M; Wolf HP
Metabolism; 1991 Nov; 40(11):1185-90. PubMed ID: 1943747
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of carnitine palmitoyltransferase-1 and -2 inhibitors on rat heart hypertrophy.
Hülsmann WC; Peschechera A; Schneijdenberg CT; Verkleij AJ
Cardioscience; 1994 Sep; 5(3):193-7. PubMed ID: 7827256
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
Zarain-Herzberg A; Rupp H
Expert Opin Investig Drugs; 2002 Mar; 11(3):345-56. PubMed ID: 11866664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
